Insider Screener
Real-time Form 4 Filtering Engine
| Filing Date | Trade Date | Ticker | Company Name | Reporting Person | Relationship | Industry (by SEC) | Type | Price | Qty | Total, $ | Owned After | Change, % |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-06-06 15:44 | 2025-06-04 | ARQT | Arcutis Biotherapeutics Inc. | Heron Patrick J | Director | Pharmaceutical Preparations | BUY | $13.34 | 2,268 | $30,247 | 24,802 | +10.1% |
| 2025-05-30 03:25 | 2025-05-28 | ARQT | Arcutis Biotherapeutics Inc. | Matsuda Masaru | Officer; See Remarks | Pharmaceutical Preparations | SALE | $13.78 | 1,800 | $24,807 | 202,599 | -0.9% |
| 2025-05-23 23:04 | 2025-05-21 | ARQT | Arcutis Biotherapeutics Inc. | Heron Patrick J | Director | Pharmaceutical Preparations | BUY | $13.66 | 5,040 | $68,821 | 22,534 | +28.8% |
| 2025-05-20 23:37 | 2025-05-19 | ARQT | Arcutis Biotherapeutics Inc. | Edwards Larry Todd | Officer; See Remarks | Pharmaceutical Preparations | SALE | $14.07 | 7,451 | $104,850 | 183,104 | -3.9% |
| 2025-05-19 23:14 | 2025-05-15 | ARQT | Arcutis Biotherapeutics Inc. | Heron Patrick J | Director | Pharmaceutical Preparations | BUY | $13.62 | 2,520 | $34,317 | 17,494 | +16.8% |
| 2025-05-15 23:18 | 2025-05-13 | ARQT | Arcutis Biotherapeutics Inc. | Heron Patrick J | Director | Pharmaceutical Preparations | BUY | $13.76 | 8,674 | $119,352 | 14,974 | +137.7% |
| 2025-05-13 23:11 | 2025-05-09 | ARQT | Arcutis Biotherapeutics Inc. | Heron Patrick J | Director | Pharmaceutical Preparations | BUY | $13.60 | 6,300 | $85,691 | 6,300 | +100.0% |
| 2025-05-10 02:45 | 2025-05-08 | ARQT | Arcutis Biotherapeutics Inc. | Burnett Patrick | Officer; See Remarks | Pharmaceutical Preparations | SALE | $13.59 | 3,871 | $52,623 | 115,468 | -3.2% |
| 2025-05-06 00:20 | 2025-05-02 | ARQT | Arcutis Biotherapeutics Inc. | Matsuda Masaru | Officer; See Remarks | Pharmaceutical Preparations | SALE | $15.20 | 5,030 | $76,453 | 204,399 | -2.4% |
| 2025-05-06 00:20 | 2025-05-02 | ARQT | Arcutis Biotherapeutics Inc. | Watanabe Todd Franklin | Director, Officer; See Remarks | Pharmaceutical Preparations | SALE | $15.19 | 11,448 | $173,917 | 913,795 | -1.2% |
| 2025-05-05 23:49 | 2025-05-01 | ARQT | Arcutis Biotherapeutics Inc. | Welgus Howard G. | Director | Pharmaceutical Preparations | SALE | $14.64 | 10,000 | $146,357 | 111,944 | -8.2% |
| 2025-05-06 00:20 | 2025-05-02 | ARQT | Arcutis Biotherapeutics Inc. | Burnett Patrick | Officer; See Remarks | Pharmaceutical Preparations | SALE | $15.19 | 2,597 | $39,442 | 119,339 | -2.1% |
| 2025-04-03 23:21 | 2025-04-01 | ARQT | Arcutis Biotherapeutics Inc. | Welgus Howard G. | Director | Pharmaceutical Preparations | SALE | $15.12 | 10,000 | $151,236 | 121,944 | -7.6% |
| 2025-04-03 23:21 | 2025-04-02 | ARQT | Arcutis Biotherapeutics Inc. | Topper David Joseph | Officer; Chief Financial Officer | Pharmaceutical Preparations | SALE | $15.80 | 9,600 | $151,698 | 182,774 | -5.0% |
| 2025-03-26 23:41 | 2025-03-24 | ARQT | Arcutis Biotherapeutics Inc. | Watanabe Todd Franklin | Director, Officer; See Remarks | Pharmaceutical Preparations | SALE | $17.55 | 3,671 | $64,414 | 925,243 | -0.4% |
| 2025-03-21 01:27 | 2025-03-17 | ARQT | Arcutis Biotherapeutics Inc. | Watanabe Todd Franklin | Director, Officer; See Remarks | Pharmaceutical Preparations | SALE | $17.61 | 1,200 | $21,137 | 928,914 | -0.1% |
| 2025-03-17 23:51 | 2025-03-13 | ARQT | Arcutis Biotherapeutics Inc. | Burnett Patrick | Officer; See Remarks | Pharmaceutical Preparations | OPT+S | $14.99 | 61,403 | $920,511 | 121,936 | -33.5% |
| 2025-03-05 03:43 | 2025-03-03 | ARQT | Arcutis Biotherapeutics Inc. | Watanabe Todd Franklin | Director, Officer; See Remarks | Pharmaceutical Preparations | SALE | $13.07 | 25,015 | $327,019 | 930,114 | -2.6% |
| 2025-03-05 03:43 | 2025-03-03 | ARQT | Arcutis Biotherapeutics Inc. | Welgus Howard G. | Director | Pharmaceutical Preparations | SALE | $13.00 | 10,000 | $130,048 | 131,944 | -7.0% |
| 2025-03-05 03:43 | 2025-03-03 | ARQT | Arcutis Biotherapeutics Inc. | Matsuda Masaru | Officer; See Remarks | Pharmaceutical Preparations | SALE | $13.03 | 3,263 | $42,520 | 209,429 | -1.5% |
| 2025-03-05 03:44 | 2025-03-03 | ARQT | Arcutis Biotherapeutics Inc. | Burnett Patrick | Officer; See Remarks | Pharmaceutical Preparations | SALE | $13.10 | 3,773 | $49,408 | 166,089 | -2.2% |
| 2025-02-05 04:01 | 2025-02-03 | ARQT | Arcutis Biotherapeutics Inc. | Matsuda Masaru | Officer; See Remarks | Pharmaceutical Preparations | SALE | $12.70 | 8,338 | $105,893 | 178,692 | -4.5% |
| 2025-02-05 04:01 | 2025-02-03 | ARQT | Arcutis Biotherapeutics Inc. | Watanabe Todd Franklin | Director, Officer; See Remarks | Pharmaceutical Preparations | SALE | $12.70 | 19,301 | $245,123 | 804,129 | -2.3% |
| 2025-02-05 04:00 | 2025-02-03 | ARQT | Arcutis Biotherapeutics Inc. | Welgus Howard G. | Director | Pharmaceutical Preparations | SALE | $12.71 | 10,000 | $127,100 | 141,944 | -6.6% |
| 2025-02-05 04:00 | 2025-02-03 | ARQT | Arcutis Biotherapeutics Inc. | Edwards Larry Todd | Officer; See Remarks | Pharmaceutical Preparations | SALE | $12.70 | 2,173 | $27,597 | 135,555 | -1.6% |
| 2025-02-05 04:00 | 2025-02-03 | ARQT | Arcutis Biotherapeutics Inc. | Burnett Patrick | Officer; See Remarks | Pharmaceutical Preparations | SALE | $12.70 | 12,116 | $153,873 | 114,862 | -9.5% |
| 2025-01-07 00:08 | 2025-01-02 | ARQT | Arcutis Biotherapeutics Inc. | Welgus Howard G. | Director | Pharmaceutical Preparations | SALE | $14.67 | 10,000 | $146,714 | 151,944 | -6.2% |
| 2025-01-01 02:13 | 2024-12-31 | ARQT | Arcutis Biotherapeutics Inc. | Burnett Patrick | Officer; See Remarks | Pharmaceutical Preparations | SALE | $14.00 | 1,691 | $23,674 | 126,978 | -1.3% |
| 2024-12-24 03:22 | 2024-12-20 | ARQT | Arcutis Biotherapeutics Inc. | Watanabe Todd Franklin | Director, Officer; See Remarks | Pharmaceutical Preparations | SALE | $15.17 | 15,000 | $227,567 | 823,430 | -1.8% |
| 2024-12-04 00:17 | 2024-11-30 | ARQT | Arcutis Biotherapeutics Inc. | Edwards Larry Todd | Officer; See Remarks | Pharmaceutical Preparations | BUY | $7.11 | 1,093 | $7,767 | 137,728 | +0.8% |
| 2024-12-04 00:16 | 2024-05-31 | ARQT | Arcutis Biotherapeutics Inc. | Matsuda Masaru | Officer; See Remarks | Pharmaceutical Preparations | BUY | $3.28 | 5,657 | $18,543 | 187,030 | +3.1% |
| 2024-12-04 00:16 | 2024-12-02 | ARQT | Arcutis Biotherapeutics Inc. | Welgus Howard G. | Director | Pharmaceutical Preparations | SALE | $12.51 | 10,000 | $125,133 | 161,944 | -5.8% |
| 2024-12-04 00:16 | 2024-05-31 | ARQT | Arcutis Biotherapeutics Inc. | Watanabe Todd Franklin | Director, Officer; See Remarks | Pharmaceutical Preparations | BUY | $3.52 | 6,038 | $21,250 | 838,430 | +0.7% |
| 2024-11-27 00:21 | 2024-11-22 | ARQT | Arcutis Biotherapeutics Inc. | Burnett Patrick | Officer; See Remarks | Pharmaceutical Preparations | OPT+S | $10.14 | 16,023 | $162,515 | 128,669 | -11.1% |
| 2024-11-20 03:52 | 2024-11-19 | ARQT | Arcutis Biotherapeutics Inc. | Matsuda Masaru | Officer; See Remarks | Pharmaceutical Preparations | SALE | $9.68 | 1,775 | $17,190 | 181,373 | -1.0% |
| 2024-11-19 03:04 | 2024-11-14 | ARQT | Arcutis Biotherapeutics Inc. | Burnett Patrick | Officer; See Remarks | Pharmaceutical Preparations | OPT+S | $10.29 | 69,226 | $712,619 | 128,669 | -35.0% |
| 2024-11-14 02:45 | 2024-11-11 | ARQT | Arcutis Biotherapeutics Inc. | Curran Terrie | Director | Pharmaceutical Preparations | SALE | $10.85 | 8,687 | $94,238 | 10,139 | -46.1% |
| 2024-11-06 00:46 | 2024-11-04 | ARQT | Arcutis Biotherapeutics Inc. | Matsuda Masaru | Officer; See Remarks | Pharmaceutical Preparations | SALE | $8.68 | 5,015 | $43,551 | 178,273 | -2.7% |
| 2024-11-06 00:46 | 2024-11-04 | ARQT | Arcutis Biotherapeutics Inc. | Watanabe Todd Franklin | Director, Officer; See Remarks | Pharmaceutical Preparations | SALE | $8.68 | 13,871 | $120,459 | 832,392 | -1.6% |
| 2024-11-06 00:46 | 2024-11-01 | ARQT | Arcutis Biotherapeutics Inc. | Welgus Howard G. | Director | Pharmaceutical Preparations | SALE | $8.65 | 10,000 | $86,541 | 171,944 | -5.5% |
| 2024-11-06 00:45 | 2024-11-04 | ARQT | Arcutis Biotherapeutics Inc. | Burnett Patrick | Officer; See Remarks | Pharmaceutical Preparations | SALE | $8.68 | 15,441 | $134,093 | 179,418 | -7.9% |
| 2024-10-03 23:55 | 2024-10-01 | ARQT | Arcutis Biotherapeutics Inc. | Welgus Howard G. | Director | Pharmaceutical Preparations | SALE | $9.26 | 10,000 | $92,616 | 181,944 | -5.2% |
| 2024-10-03 23:55 | 2024-10-02 | ARQT | Arcutis Biotherapeutics Inc. | Edwards Larry Todd | Officer; SVP Chief Commercial Officer | Pharmaceutical Preparations | SALE | $10.01 | 3,725 | $37,295 | 136,635 | -2.7% |
| 2024-09-26 04:42 | 2024-09-24 | ARQT | Arcutis Biotherapeutics Inc. | Topper David Joseph | Officer; Chief Financial Officer | Pharmaceutical Preparations | SALE | $9.48 | 11,626 | $110,264 | 158,374 | -6.8% |
| 2024-09-06 00:56 | 2024-09-03 | ARQT | Arcutis Biotherapeutics Inc. | Welgus Howard G. | Director | Pharmaceutical Preparations | SALE | $10.77 | 10,000 | $107,695 | 191,944 | -5.0% |
| 2024-08-21 23:39 | 2024-08-19 | ARQT | Arcutis Biotherapeutics Inc. | Burnett Patrick | Officer; See Remarks | Pharmaceutical Preparations | SALE | $8.29 | 1,728 | $14,318 | 194,859 | -0.9% |
| 2024-08-05 23:37 | 2024-08-02 | ARQT | Arcutis Biotherapeutics Inc. | Matsuda Masaru | Officer; See Remarks | Pharmaceutical Preparations | SALE | $9.02 | 5,220 | $47,064 | 183,288 | -2.8% |
| 2024-08-05 23:37 | 2024-08-02 | ARQT | Arcutis Biotherapeutics Inc. | Watanabe Todd Franklin | Director, Officer; See Remarks | Pharmaceutical Preparations | SALE | $9.02 | 14,487 | $130,648 | 846,263 | -1.7% |
| 2024-08-05 23:37 | 2024-08-01 | ARQT | Arcutis Biotherapeutics Inc. | Welgus Howard G. | Director | Pharmaceutical Preparations | OPT+S | $9.87 | 10,000 | $98,696 | 176,953 | -5.3% |
| 2024-08-05 23:37 | 2024-08-02 | ARQT | Arcutis Biotherapeutics Inc. | Burnett Patrick | Officer; See Remarks | Pharmaceutical Preparations | SALE | $9.02 | 13,206 | $119,106 | 196,587 | -6.3% |
Strategic Signal Filtering
Our screener allows you to cut through the noise of routine stock grants and small trades. By focusing on high-value transactions from C-suite executives (CEO/CFO), you can identify where the "Smart Money" is being deployed with maximum conviction.
Investing Without Illusions
Insider data is not a magic wand, but it is the most honest indicator available. While insiders sell for many reasons (taxes, personal needs), they generally buy for only one: they believe the stock price is undervalued. We provide the tools to track these skin-in-the-game moves.
UNDERSTANDING THE DATA
FILING DATE: The date and time when the transaction was reported to the SEC. This is when the public first receives the information.
TRADE DATE: The actual day the insider executed the purchase or sale in the market.
INDUSTRY: The specific market sector the company operates in. Useful for identifying broader institutional capital flows across sectors.
OWNED AFTER: The total number of shares held by the insider following the transaction. This highlights the insider's remaining conviction in the company.
CHANGE %: The percentage increase or decrease of the insider's total position. Large percentage changes often carry more weight than the dollar amount alone.
TRADE TYPES DEFINITIONS
BUY: An open market purchase. Typically indicates an insider's belief that the stock is undervalued or poised for growth.
SELL: An open market sale. While often used for diversification or liquidity, large or unexpected sales can be a warning signal.
OPT+S (OPTION EXERCISE & SALE): This occurs when an insider exercises their stock options and sells them immediately. Often part of a structured compensation plan.